Northwest Biotherapeutics Announces Establishment Of the Company’s Own Dedicated Leukapheresis Clinic

B BETHESDA, Md., April 21, 2026 /PRNewswire/ — Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the “Company” or “NWBio”), a biotechnology company developing DCVax® personalized immune therapies for…
posteditor
posteditor
Articles: 21727

Other News